Clincosm LogoSign in Get a demo

Myeloproliferative Disorders

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid

Suspended
  • Thrombocytopenia
  • +5 more
  • Thrombosomes
  • Liquid Stored Platelets (LSP)
  • Duarte, California
  • +5 more
Apr 21, 2022

Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

Not yet recruiting
  • Myeloproliferative Disorders
  • Lymphoproliferative Disorders
  • Blood collection for the evaluation of the anti-drugs sensitivity
  • Pierre-Bénite, France
  • +1 more
Mar 2, 2022

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Pathogenesis of Hematologic Malignancies

    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Feb 17, 2022

    Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

    Recruiting
    • Allogeneic Hematopoietic Cell Transplantation (HCT)
    • +5 more
    • Purified regulatory T-cells (Treg) plus CD34+ HSPC
    • +7 more
    • Stanford, California
      Stanford University
    Oct 28, 2021

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

    Withdrawn
    • Acute Myeloid Leukemia
    • +7 more
    • MDG1021 dose 1
    • +3 more
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Centre
    Sep 30, 2021

    Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +3 more
    • standard of care.
    • (no location specified)
    Sep 14, 2021

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

    Terminated
    • Leukemia, Myeloid, Acute
    • +8 more
    • Mesenchymal stem cells
    • Isotonic solution
    • Edeghem, Antwerpen, Belgium
    • +9 more
    Aug 31, 2021

    Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

    Recruiting
    • Cancer, Metastatic
    • +42 more
    • Clinical Trial Matching
    • New York, New York
      Massive Bio, Inc
    May 21, 2021

    Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +3 more
    • anti-thymocyte globulin
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Oct 30, 2020

    Pulmonary Hypertension in Myeloproliferative Neoplasms

    Completed
    • Myeloproliferative Disorders
    • Pulmonary Hypertension
    • Radiology
    • Odense, Denmark
      Odense University Hospital
    Sep 15, 2020

    Dysregulated Signaling in MPD Via Multiparameter

    Terminated
    • Myeloproliferative Disorders
    • Myeloproliferative Disorders (MPD)
      • Stanford, California
        Stanford University School of Medicine
      Apr 7, 2020

      Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disorders Trial in Perugia (High dose irradiation

      Recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • High dose irradiation conditioning + Treg/Tcon
      • Perugia, PG, Italy
        University of Perugia
      Jan 8, 2020

      Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)

      Completed
      Has Results
      • Neural Tube Defects
      • +5 more
      • CIK cells
      • +4 more
      • Stanford, California
        Stanford University School of Medicine
      Apr 18, 2019

      Primary Myelofibrosis, Myeloproliferative Disorders Trial in Saint-Petersburg (Allogeneic hematopoietic stem cell

      Completed
      • Primary Myelofibrosis
      • Myeloproliferative Disorders
      • Allogeneic hematopoietic stem cell transplantation
      • +4 more
      • Saint-Petersburg, Russian Federation
        First Pavlov State Medical University of St. Petersburg
      Apr 3, 2019

      Lymphoma, Leukemia, Myeloproliferative Disorders Trial in Bethesda, Hackensack (drug, procedure, genetic)

      Terminated
      Has Results
      • Lymphoma
      • +4 more
      • Bethesda, Maryland
      • +1 more
      Dec 28, 2018

      Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Myelocytic Leukemia Trial run by the NHLBI (Isolex 300i Stem Cell

      Completed
      • Acute Lymphocytic Leukemia
      • +4 more
      • Isolex 300i Stem Cell Selection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 25, 2018

      Acute Leukemia, MDS, Myeloproliferative Disorders Trial in Marseille (Blood sampling, Bone marrow aspirate, Skin biopsy)

      Recruiting
      • Acute Leukemia
      • +2 more
      • Blood sampling
      • +3 more
      • Marseille, France
        Institut Paoli-Calmettes
      Jul 24, 2018

      Resistance of Stem Cells Myeloproliferative Opposite of Tyrosine

      Unknown status
      • Myeloproliferative Disorders
        • Nice, France
          CHU de Nice
        Jul 23, 2018

        Myeloproliferative Disorders, Thrombocythemia, Essential, Polycythemia Vera Trial in Houston, Salt Lake City (LY2784544)

        Completed
        • Myeloproliferative Disorders
        • +3 more
        • Houston, Texas
        • +1 more
        Apr 13, 2018

        Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

        Terminated
        • Myelodysplastic Syndrome
        • +9 more
        • Phoenix, Arizona
        • +6 more
        Feb 13, 2018

        Myeloproliferative Disorders, Leukemia, Lymphoma Trial (umbilical cord blood transplantation)

        Terminated
        Has Results
        • Myeloproliferative Disorders
        • +3 more
        • umbilical cord blood transplantation
        • (no location specified)
        Dec 3, 2017

        Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Minneapolis (Leuprolide, hematopoietic cell transplant, reduced

        Terminated
        Has Results
        • Multiple Myeloma
        • +4 more
        • Minneapolis, Minnesota
          Masonic Cancer Center, University of Minnesota
        Dec 3, 2017